Results 181 to 190 of about 898,102 (296)

The Microbiome in Cancer: Composition, Mechanisms, and Therapeutic Implications

open access: yesMedComm, Volume 7, Issue 12, December 2026.
1. This paper proposes the “oncobiome” as a unifying conceptual framework that integrates commensal, pathobiont, and tumor‐resident microbes into a coherent biological processor driving malignancy. 2. This study describes the dynamic shift from a homeostatic microbiome to a pathological oncobiome, detailing how diet, antibiotics, and environment ...
Xuan Zhang   +6 more
wiley   +1 more source

Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ<sub>1</sub>R Agonists/HDAC Inhibitor Dual-Acting Compounds. [PDF]

open access: yesChemMedChem
Fallica AN   +16 more
europepmc   +1 more source

A Voxel‐Wise T2 Distribution Framework for Lesion Severity Stratification and Treatment‐Response Assessment in Stroke: Insights Into Suberoylanilide Hydroxamic Acid‐Induced Neuroprotection

open access: yesMagnetic Resonance in Medicine, Volume 96, Issue 6, Page 2870-2884, December 2026.
ABSTRACT Purpose To evaluate lesion severity distribution in ischaemic brain lesions in spontaneously hypertensive rats (SHR) subjected to 90‐min transient middle cerebral artery occlusion (tMCAO), and to determine whether epigenetically based neuroprotection modifies lesion severity profiles using a voxel‐wise T2 distribution framework.
Andrea Díaz‐Pérez   +3 more
wiley   +1 more source

Immunometabolic Modulation by Low‐Dose Sodium Butyrate: PI3K/Akt/mTOR Signalling Orchestrates Macrophage Polarization to Protect Against Clostridioides difficile Colitis

open access: yesImmunology, Volume 179, Issue 4, Page 594-608, December 2026.
Clostridioides difficile toxins TcdA and TcdB enter intestinal epithelial cells (IECs) via specific receptors, disrupt tight‐junction integrity and activate PI3K/Akt/mTOR signalling, promoting inflammasome assembly and IL‐1β release. Toxin‐induced IEC apoptosis further weakens the epithelial barrier.
Sisi Zhang   +7 more
wiley   +1 more source

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active. [PDF]

open access: yesNat Commun
Sequera C   +24 more
europepmc   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, Volume 600, Issue 21, Page 3221-3240, November 2026.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [PDF]

open access: yesClin Epigenetics
Yang H   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy